EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL
Go back to EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL| Edwards Lifesciences (NYSE: EW) | Delayed: 81.64 -2.25 (2.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $83.89 | 52 Week High | $166.87 | |||
| Open | $83.00 | 52 Week Low | $72.20 | |||
| Day High | $83.08 | P/E | 23.73 | |||
| Day Low | $80.50 | EPS | $3.44 | |||
| Volume | 5,223,768 | |||||
